Clinical trials
Completed Pancreatic Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 8 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Radboud University Medical Center | 3 |
| Amgen | 2 |
| Amsterdam UMC, location VUmc | 2 |
| Eli Lilly and Company | 2 |
| Hoffmann-La Roche | 2 |
| Novartis Pharmaceuticals | 2 |
| Array Biopharma, now a wholly owned subsidiary of Pfizer | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 44 |
| Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Ovarian Neoplasms | 4 |
| Pancreatic Diseases | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Digestive System Diseases | 3 |
| Digestive System Neoplasms | 3 |
| Endocrine Gland Neoplasms | 3 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.